Osteopontin-Targeted and PPARδ-Agonist-Loaded Nanoparticles Efficiently Reduce Atherosclerosis in Apolipoprotein E(–/–) Mice

[Image: see text] Atherosclerosis is the leading cause of vascular pathologies and acute cardiovascular events worldwide. Early theranostics of atherosclerotic plaque formation is critical for the prevention of associated cardiovascular complications. Osteopontin (OPN) expression in vascular smooth...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xu, Zhang, Yang, Zhang, Weiwei, Qin, Cheng, Zhu, Yan, Fang, Yan, Wang, Yabin, Tang, Chengchun, Cao, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404512/
https://www.ncbi.nlm.nih.gov/pubmed/36033674
http://dx.doi.org/10.1021/acsomega.2c00575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404512/
https://www.ncbi.nlm.nih.gov/pubmed/36033674
http://dx.doi.org/10.1021/acsomega.2c00575

Ejemplares similares